http://www.legislation.gov.uk/id/uksi/1994/3142

http://www.legislation.gov.uk/uksi/1994/3142/regulation/9/made

The Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

Community health clinics

Community health services

King's Printer of Acts of Parliament

2016-08-31

MEDICINES

These Regulations implement Council Directive 93/40/EEC, which is the latest in a series of amendments to Council Directive 81/851/EEC. They provide for veterinary medicinal products to be placed on the market subject to marketing authorisations rather than the previous system of product licences. These authorisations may be granted either by the Ministers or, in accordance with Council Regulation 2309/93/EEC, by the European Agency for the Evaluation of Medicinal Products (regulation 3).

The Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

Regulations

The Transfer of Functions (Medicines and Poisons) Order 1999

art. 2(3)

art. 3

art. 1(2)

Marketing Authorisations for Veterinary Medicinal Products Regs

The Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

Instrument

Scotland Act 1998

s.30

Sch.5 Pt.II

s.J4(a)

The Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

reg. 6(2)(b)

(iiiA)

(iiiB)

The Medicated Feedingstuffs and Feedingstuffs (Zootechnical Products) (Consequential Provisions) Regulations 1998

Sch. 2

para. 2

reg. 1

The Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

Act

The Transfer of Functions (Medicines and Poisons) Order 1999

art.2(3)

The Marketing Authorisations for Veterinary Medicinal Products Regulations 1994

Regulations

The Veterinary Medicines Regulations 2005

Sch. 8

Pt. 1

Sch. 8

Pt. 4

reg. 1(a)

Marketing Authorisations for Veterinary Medicinal Products Regs

Variations of authorisations9

The Ministers may, on the application of the holder of a marketing authorisation, vary the conditions relating to the authorisation in accordance with any proposals contained in the application, if they are satisfied that the variation will not adversely affect the safety, quality or efficacy of a product of any description to which the authorisation relates.